Mangia, A.; Cenderello, G.; Copetti, M.; Verucchi, G.; Piazzolla, V.; Lorusso, C.; Santoro, R.; Squillante, M.M.; Orlandini, A.; Minisini, R.;
et al. SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study. Cells 2019, 8, 313.
https://doi.org/10.3390/cells8040313
AMA Style
Mangia A, Cenderello G, Copetti M, Verucchi G, Piazzolla V, Lorusso C, Santoro R, Squillante MM, Orlandini A, Minisini R,
et al. SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study. Cells. 2019; 8(4):313.
https://doi.org/10.3390/cells8040313
Chicago/Turabian Style
Mangia, Alessandra, Giovanni Cenderello, Massimiliano Copetti, Gabriella Verucchi, Valeria Piazzolla, Celeste Lorusso, Rosanna Santoro, Maria Maddalena Squillante, Alessandra Orlandini, Rosalba Minisini,
and et al. 2019. "SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study" Cells 8, no. 4: 313.
https://doi.org/10.3390/cells8040313
APA Style
Mangia, A., Cenderello, G., Copetti, M., Verucchi, G., Piazzolla, V., Lorusso, C., Santoro, R., Squillante, M. M., Orlandini, A., Minisini, R., & Ciancio, A.
(2019). SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study. Cells, 8(4), 313.
https://doi.org/10.3390/cells8040313